Regulation of GTP cyclohydrolase I by alternative splicing in mononuclear cells

Biochemical and Biophysical Research Communications

Volumn 306, Issue 4, 2003, Pages 937-942

  Hwu, Wuh Liang ^a   Yeh, Hui Ying ^a   Fang, Shu Wen ^a   Chiang, Hao Sen ^a   Chiou, Yu Wei ^b   Lee, Yu May ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Alternative splicing; Dominant negative effect; GTP cyclohydrolase I; Regulation

Indexed keywords

AROMATIC AMINO ACID; COMPLEMENTARY DNA; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; MESSENGER RNA; NITRIC OXIDE SYNTHASE; OXYGENASE; TETRAHYDROBIOPTERIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BLOOD CELL; CONTROLLED STUDY; ENZYME REGULATION; GENETIC CODE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; WILD TYPE;

EID: 0038095340     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01091-X     Document Type: Article

References (35)

1. Nichol C.A., Smith G.K., Duch D.S. Biosythesis and metabolism of tetrahydrobiopterin and molybdopterin. Ann. Rev. Biochem. 54:1985;729-764.
2. Kaufman S. Studies on the mechanism of the enzymatic conversion of phenylalanine to tyrosine. J. Biol. Chem. 234:1959;2677-2682.
3. Nagatsu T., Levitt M., Udenfriend S. Tyrosine hydroxylase: the initial step in norepinephrine biosynthesis. J. Biol. Chem. 239:1964;2910-2917.
4. Griffith O.W., Dennis J.S. Nitric oxide synthase: properties and catalytic mechanism. Ann. Rev. Physiol. 57:1995;707-736.
5. Thony B., Blau N. Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes. Hum. Mutat. 10:1997;11-20.
6. Niederwieser A., Blau N., Wang M., Joller P., Atarés M., Cardesa-Garcia J. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur. J. Pediatr. 141:1984;208-214.
7. Segawa M., Hosaka A., Migagawa F., Nomura Y., Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Eldridge R., Fahn S. Dystonia, Advance in Neurology. 1976;215-233 Raven, New York.
8. Ichinose H., Nagatsu T. Molecular genetics of hereditary dystonia - mutations in the GTP cyclohydrolase I gene. Brain Res. Bull. 43:1997;35-38.
9. Hwu W.L., Wang P.J., Hsiao K.J., Wang T.R., Lee Y.M. Dopa-responsive dystonia induced by recessive GTP cyclohydrolase I mutation. Hum. Genet. 105:1999;226-230.
10. Nar H., Huber R., Meining W., Schmid C., Weinkauf S., Bacher A. Atomic structure of GTP cyclohydrolase I. Structure. 3:1995;459-466.
11. Hwu W.L., Chiou Y.W., Lai S.Y., Lee Y.M. Dopa-responsive dystonia is induced by a dominant-negative mechanism. Ann. Neurol. 48:2000;609-613.
12. Togari A., Arai M., Mogi M., Kondo A., Nagatsu T. Coexpression of GTP cyclohydrolase I and inducible nitric oxide synthase mRNAs in mouse osteoblastic cells activated by proinflammatory cytokines. FEBS Lett. 428:1998;212-216.
13. Bune A.J., Brand M.P., Heales S.J., Shergill J.K., Cammack R., Cook H.T. Inhibition of tetrahydrobiopterin synthesis reduces in vivo nitric oxide production in experimental endotoxic shock. Biochem. Biophys. Res. Commun. 220:1996;13-19.
14. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayer G., Werner E.R. L-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 276:2001;40-47.
15. Kapatos G., Stegenga S.L., Hirayama K. Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat GTP cyclohydrolase I gene. J. Biol. Chem. 275:2000;5947-5957.
16. Togari A., Ichinose H., Matsumoto S., Fujita K., Nagatsu T. Multiple mRNA forms of human GTP cyclohydrolase I. Biochem. Biophys. Res. Commun. 187:1992;359-365.
17. Nomura T., Ohtsuki M., Matsui S., Sumi-Ichinose C., Nomura H., Hagino Y., Iwase K., Ichinose H., Fujita K., Nagatsu T. Isolation of a full-length cDNA clone for human GTP cyclohydrolase I type 1 from pheochromocytoma. J. Neural. Transm. 101:1995;237-242.
18. Golderer G., Werner E.R., Heufler C., Strohmaier W., Grobner P., Werner-Felmayer G. GTP cyclohydrolase I mRNA: novel splice variants in the slime mould Physarum polycephalum and in human monocytes (THP-1) indicate conservation of mRNA processing. Biochem. J. 355:2001;499-507.
19. Ichinose H., Ohye T., Matsuda Y., Hori T., Blau N., Burlina A., Rouse B., Matalon R., Fujita K., Nagatsu T. Charaterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency. J. Biol. Chem. 270:1995;10062-10071.
20. Lee Y.M., Miau L.W., Chang C.J., Lee S.C. Transcriptional induction of alpha-1 acid glycoprotein gene by synergistic interaction of two alternative activator forms of AGP/EBP (C/EBP. β) and NF-kB or Nopp140 Mol. Cell. Biol. 16:1996;4257-4263.
21. Wittwer C.T., Ririe K.M., Andrew R.V., David D.A., Gundry R.A., Balis U.J. The LightCyclerk: a microvolume multisample fluorimeter with rapid temperature control. Bio-Techniques. 22:1997;176-181.
22. Graham F., van der Erb A. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-457.
23. Fu X.D., Maniatis T. Factor required for mammalian spliceosome assembly is localized to discrete regions in he nucleus. Nature. 343:1990;437-444.
24. Mayeda A., Krainer A.R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell. 68:1992;365-375.
25. Gil A., Sharp P.A., Jamison S.F., Garcia-Blanco M.A. Characterization of cDNAs encoding the polypyrimidine tract-binding protein. Genes Dev. 5:1991;1224-1236.
26. Screaton G.R., Caceres J.F., Mayeda A., Bell M.V., Plebanski M., Jackson D.G., Bell J.I., Krainer A.R. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO. 14:1995;4336-4349.
27. Tacke R., Tohyama M., Ogawa S., Manley J.L. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell. 93:1998;139-148.
28. Blau N., Joller P., Atares M., Cardesa-Garcia J., Niederwieser A. Increase of GTP cyclohydrolase I activity in mononuclear blood cells by stimulation: detection of heterozygotes of GTP cyclohydrolase I deficiency. Clin. Chim. Acta. 148:1985;47-52.
29. Gutlich M., Jaeger E., Rucknagel K.P., Werner T., Rodl W., Ziegler I., Bacher A. Human GTP cyclohydrolase I: only one out of three cDNA isoforms gives rise to the active enzyme. Biochem. J. 15:1994;215-221.
30. Caceres J.F., Kornblihtt A.R. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18:2002;186-193.
31. Hanamura A., Caceres J.F., Mayeda A., Franza B.R. Jr., Krainer A.R. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA. 4:1998;430-444.
32. Hirano M., Imaiso Y., Ueno S. Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia. Biochem. Biophys. Res. Commun. 234:1997;316-319.
33. Dreyfuss G., Matunis M.J., Pinol-Roma S., Burd C.G. hnRNP proteins and the biogenesis of mRNA. Ann. Rev. Biochem. 62:1993;289-321.
34. Fu X.D. The superfamily of arginine/serine-rich splicing factors. RNA. 1:1995;663-680.
35. Proudfoot N. Connecting transcription to messenger RNA processing. TIBS. 25:2000;290-293.